Noxopharm Limited (ASX:NOX)
Noxopharm Limited (ASX:NOX)
  • About Us
    • About Noxopharm
    • CEO's Message
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Our Network
    • Pharmorage
    • ESG Commitment
  • Technology
    • Technology Platforms
    • Sofra™
      • RNA Vaccines and Therapeutics
      • Autoimmune Disease
      • Immuno-oncology
      • Scientific Background
        • Nucleic Acid Sensors
        • Oligonucleotides
        • The Immune System
    • Chroma™
  • Clinical Trials
  • Publications & Events
  • Investor Centre
    • Share Price
    • ASX Announcements
    • Presentations, Interviews & Media
    • Annual Reports
    • Financial Reports
    • Corporate Governance
    • Investor Fact Sheet
    • Share Registry Information
  • Contact Us
    • Contact Us
    • Partnering
    • Working at Noxopharm
    • ASX Announcements Email Alerts
Investor Centre
Investor Centre > Presentations, Interviews & Media
  • Share Price
  • ASX Announcements
  • Presentations, Interviews & Media
  • Annual Reports
  • Financial Reports
  • Corporate Governance
  • Investor Fact Sheet
  • Share Registry Information

Presentations, Interviews & Media

Filter by Year:2026 2025 2024 2023 2022 
21-Aug-2026
CEO Letter – Reflections on global mRNA cancer vaccine news
11-Aug-2026
CEO Dr Olivier Laczka discusses Nature Immunology paper
26-Jul-2026
ASX Briefs interview with Dr Olivier Laczka
16-Jul-2026
Hudson Institute partnership video with Dr Olivier Laczka
12-Jun-2026
CEO Dr Olivier Laczka interview with Proactive Investors
22-May-2026
Sofra technology draws global interest as CSL to present vaccine delivery data
22-Apr-2026
Noxopharm flags prolonged skin retention data for SOF-SKN as it moves toward human trial
21-Apr-2026
Noxopharm appoints Dr Olivier Laczka as Chief Executive Officer | BioMelbourne Network
13-Feb-2026
Noxopharm says paper reveals science behind its immune system platform
10-Feb-2026
Tiny one- to three-base RNAs could help stop autoimmune inflammation, study suggests
  • 1
  • 2
  •  Next

Quick Links

Location

Noxopharm Limited
Suite 71
159 Ridgecrop Drive
Sydney - Castle Hill
NSW 2154
Telephone:
+ 61 2 9144 2223

ABN
50 608 966 123

Contact us

Email Shareholder enquiries:
info@noxopharm.com
Patient enquiries:
medical.information@noxopharm.com
My shareholding:
www.automicgroup.com.au

Stay in Touch

To join Email Alerts, simply fill in your details using the form below and nominate which announcements you would like to receive.

-->

Which of the following group do you best fit?

 
Privacy

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Noxopharm Limited (ASX:NOX)
Site Map Privacy Search
Website by Proactive Digital Solutions